Thomas Berger (T Berger)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 30

Top Venues

Multiple sclerosis (Houndmills, Basingstoke, England)

Multiple sclerosis journal - experimental, translational and clinical

Therapeutic advances in neurological disorders

Nature reviews. Neurology

Medical University of Vienna

UMIT - Private Universität für Gesundheitswissenschaften, Medizinische Informatik und Technik (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Medical University of Vienna Nov 01 2018

Austria

Chair/Professor of Neurology :: Neurology

Medical University of Innsbruck Jul 01 1995 - Oct 31 2018

Austria

Vice-Chair, Associated Professor :: Neurology

Education History

UMIT - Private Universität für Gesundheitswissenschaften, Medizinische Informatik und Technik Oct 01 2003 - Mar 04 2005

Austria

MSC :: Health Economics

Publications

Gabriel Bsteh, Marie L Aicher, Janette F Walde, Nik Krajnc, Lukas Haider, Gerhard Traxler, Christiane Gradl, Salmen Anke, Katharina Riedl, Paulina Poskaite, Philipp Leyendecker, Patrick Altmann, Michael Auer, Klaus Berek, Franziska Di Pauli, Barbara Kornek, Fritz Leutmezer, Paulus Stefan Rommer, Gudrun Zulehner, Tobias Zrzavy, Florian Deisenhammer, Andrew Chan, Thomas Berger, Robert Hoepner, Helly Hammer, Harald Hegen
Association of Disease-Modifying Treatment With Outcome in Patients With Relapsing Multiple Sclerosis and Isolated MRI Activity. Neurology 103 (6) (2024)
Nik Krajnc, Victor Schmidbauer, Joel Leinkauf, Lukas Haider, Gabriel Bsteh, Gregor Kasprian, Fritz Leutmezer, Barbara Kornek, Paulus Stefan Rommer, Thomas Berger, Hans Lassmann, Assunta Dal-Bianco, Simon Hametner
Paramagnetic rim lesions lead to pronounced diffuse periplaque white matter damage in multiple sclerosis. Multiple sclerosis (Houndmills, Basingstoke, England) (2023)
Eva Hečková, Assunta Dal-Bianco, Bernhard Strasser, Gilbert J Hangel, Alexandra Lipka, Stanislav Motyka, Lukas Hingerl, Paulus Stefan Rommer, Thomas Berger, Petra Hnilicová, Ema Kantorová, Fritz Leutmezer, Egon Kurča, Stephan Gruber, Siegfried Trattnig, Wolfgang Bogner
Extensive Brain Pathologic Alterations Detected with 7.0-T MR Spectroscopic Imaging Associated with Disability in Multiple Sclerosis. Radiology 303 (1) (2022)
Klaus Berek, Harald Hegen, Jakob Hocher, Michael Auer, Franziska Di Pauli, Nik Krajnc, Reinhard Angermann, Robert Barket, Anne Zinganell, Katharina Riedl, Florian Deisenhammer, Thomas Berger, Gabriel Bsteh
Retinal layer thinning as a biomarker of long-term disability progression in multiple sclerosis. Multiple sclerosis (Houndmills, Basingstoke, England) 28 (12) (2022)
Gabriel Bsteh, Harald Hegen, Klaus Berek, Patrick Altmann, Michael Auer, Franziska Di Pauli, Lukas Haider, Fritz Leutmezer, Paulus Stefan Rommer, Lisa-Maria Walchhofer, Sebastian Wurth, Anne Zinganell, Florian Deisenhammer, Thomas Berger
Olfactory threshold predicts treatment response in relapsing multiple sclerosis. Multiple sclerosis (Houndmills, Basingstoke, England) 28 (10) (2022)
Nik Krajnc, Assunta Dal-Bianco, Fritz Leutmezer, Gregor Kasprian, Berthold Pemp, Barbara Kornek, Thomas Berger, Paulus Stefan Rommer, Simon Hametner, Hans Lassmann, Gabriel Bsteh
Association of paramagnetic rim lesions and retinal layer thickness in patients with multiple sclerosis. Multiple sclerosis (Houndmills, Basingstoke, England) (2022)
Nik Krajnc, Assunta Dal-Bianco, Fritz Leutmezer, Gregor Kasprian, Berthold Pemp, Barbara Kornek, Thomas Berger, Paulus Stefan Rommer, Simon Hametner, Hans Lassmann, Gabriel Bsteh
Association of paramagnetic rim lesions and retinal layer thickness in patients with multiple sclerosis. Multiple sclerosis (Houndmills, Basingstoke, England) 29 (3) (2022)
Katina Aleksovska, Claudio Lino Alberto Bassetti, Thomas Berger, Vanessa Carvalho, João N Costa, Guenther Deuschl, Kristian Steen Frederiksen, Joke Jaarsma, Teia Kobulashvili, Maurizio Angelo Leone, Lucia Pavlakova, Michele Romoli, Luca Vignatelli
Prioritization process for European Academy of Neurology clinical practice guidelines. European journal of neurology (2022)
Romana Höftberger, Hans Lassmann, Thomas Berger, Markus Reindl
Pathogenic autoantibodies in multiple sclerosis - from a simple idea to a complex concept. Nature reviews. Neurology 18 (11) (2022)
Nik Krajnc, Assunta Dal-Bianco, Fritz Leutmezer, Gregor Kasprian, Berthold Pemp, Barbara Kornek, Thomas Berger, Paulus Stefan Rommer, Simon Hametner, Hans Lassmann, Gabriel Bsteh
Association of paramagnetic rim lesions and retinal layer thickness in patients with multiple sclerosis. Multiple sclerosis (Houndmills, Basingstoke, England) 29 (3) (2022)
Patrick Altmann, Dominik Ivkic, Markus Ponleitner, Fritz Leutmezer, Ulrike Willinger, Michaela Schmoeger, Thomas Berger, Gabriel Bsteh, Henriette Löffler-Stastka
Individual Perception of Telehealth: Validation of a German Translation of the Telemedicine Perception Questionnaire and a Derived Short Version. International journal of environmental research and public health 19 (2) (2022)
Lisa Voggenberger, Marion Böck, Doris Moser, Gudrun Lorbeer, Patrick Altmann, Fritz Leutmezer, Thomas Berger, Stefan Seidel
Bright light therapy as a non-pharmacological treatment option for multiple sclerosis-related fatigue: A randomized sham-controlled trial. Multiple sclerosis journal - experimental, translational and clinical 8 (4) (2022)
Gabriel Bsteh, Thomas Berger
Reply to letter to the editor: Olfactory threshold as a biomarker of disease activity. Multiple sclerosis (Houndmills, Basingstoke, England) (2022)
Paulus Stefan Rommer, Gabriel Bsteh, Thomas Berger, Uwe Klaus Zettl
SARS-CoV-2 antibodies in multiple sclerosis patients depending on the vaccine mode of action? Multiple sclerosis (Houndmills, Basingstoke, England) (2021)
Natascha Schurz, Lydia Sariaslani, Patrick Altmann, Fritz Leutmezer, Christoph Mitsch, Berthold Pemp, Paulus Rommer, Tobias Zrzavy, Thomas Berger, Gabriel Bsteh
Evaluation of Retinal Layer Thickness Parameters as Biomarkers in a Real-World Multiple Sclerosis Cohort. Eye and brain 13 (2021)
Gabriel Bsteh, Sophie Dürauer, Hamid Assar, Harald Hegen, Bettina Heschl, Fritz Leutmezer, Franziska Di Pauli, Christiane Gradl, Gerhard Traxler, Gudrun Zulehner, Paulus Stefan Rommer, Peter Wipfler, Michael Guger, Romana Höftberger, Christian Enzinger, Thomas Berger
Humoral immune response after COVID-19 in multiple sclerosis: A nation-wide Austrian study. Multiple sclerosis (Houndmills, Basingstoke, England) 27 (14) (2021)
Thomas Berger, Barbara Kornek
T cells step up after SARS-CoV-2 vaccination with B cell depletion. Nature reviews. Neurology 17 (12) (2021)
Heinz Wiendl, Ralf Gold, Thomas Berger, Tobias Derfuss, Ralf A Linker, Mathias Mäurer, Orhan Aktas, Karl Baum, Martin Berghoff, Stefan Bittner, Andrew Chan, Adam Czaplinski, Florian Deisenhammer, Franziska Di Pauli, Renaud Du Pasquier, Christian Enzinger, Elisabeth Fertl, Achim Gass, Klaus Gehring, Claudio Gobbi, Norbert Goebels, Michael Guger, Hans-Peter Hartung, Hans-Peter Hartung, Fedor Heidenreich, Olaf Hoffmann, Boris Kallmann, Christoph Kleinschnitz, Luisa Klotz, Verena I Leussink, Fritz Leutmezer, Volker Limmroth, Jan D Lünemann, Andreas Lutterotti, Sven G Meuth, Uta Meyding-Lamadé, Michael Platten, Peter Rieckmann, Stephan Schmidt, Hayrettin Tumani, Frank Weber, Martin S Weber, Uwe K Zettl, Tjalf Ziemssen, Frauke Zipp, null null
Multiple Sclerosis Therapy Consensus Group (MSTCG): position statement on disease-modifying therapies for multiple sclerosis (white paper). Therapeutic advances in neurological disorders 14 (2021)
Patrick Altmann, Werner Hinterberger, Fritz Leutmezer, Markus Ponleitner, Tobias Monschein, Tobias Zrzavy, Gudrun Zulehner, Barbara Kornek, Rupert Lanzenberger, Klaus Berek, Paulus Stefan Rommer, Thomas Berger, Gabriel Bsteh
The Smartphone App haMSter for Tracking Patient-Reported Outcomes in People With Multiple Sclerosis: Protocol for a Pilot Study. JMIR research protocols 10 (5) (2021)
Stephan Blechinger, Johannes Ehler, Gabriel Bsteh, Alexander Winkelmann, Fritz Leutmezer, Stefanie Meister, Agnes Santer, Michael Hecker, Thomas Berger, Paulus Stefan Rommer, Uwe Klaus Zettl
Therapeutic plasma exchange in steroid-refractory multiple sclerosis relapses. A retrospective two-center study. Therapeutic advances in neurological disorders 14 (2021)
Gabriel Bsteh, Klaus Berek, Harald Hegen, Patrick Altmann, Sebastian Wurth, Michael Auer, Anne Zinganell, Franziska Di Pauli, Paulus Stefan Rommer, Fritz Leutmezer, Florian Deisenhammer, Thomas Berger
Macular ganglion cell-inner plexiform layer thinning as a biomarker of disability progression in relapsing multiple sclerosis. Multiple sclerosis (Houndmills, Basingstoke, England) 27 (5) (2020)
Gabriel Bsteh, Harald Hegen, Patrick Altmann, Klaus Berek, Michael Auer, Anne Zinganell, Franziska Di Pauli, Paulus Stefan Rommer, Fritz Leutmezer, Florian Deisenhammer, Thomas Berger
Inner nuclear layer and olfactory threshold are interlinked and reflect inflammatory activity in multiple sclerosis. Multiple sclerosis journal - experimental, translational and clinical 6 (3) (2020)
Sherif M Hamdy, Maged Abdel Naseer, Hatem S Shehata, Amr Hassan, Alaa Elmazny, Nevin M Shalaby, Noha T Abokrysha, Nirmeen A Kishk, Mona A F Nada, Sandra M Ahmed, Mohamed I Hegazy, Doaa Mekkawy, Husam S Mourad, Ahmed Abdelalim, Thomas Berger
Managing Disease-Modifying Therapies and Breakthrough Activity in Multiple Sclerosis Patients During the COVID-19 Pandemic: Toward an Optimized Approach. Therapeutics and clinical risk management 16 (2020)
Gabriel Bsteh, Harald Hegen, Patrick Altmann, Michael Auer, Klaus Berek, Franziska Di Pauli, Sebastian Wurth, Anne Zinganell, Paulus Stefan Rommer, Florian Deisenhammer, Fritz Leutmezer, Thomas Berger
Retinal layer thinning is reflecting disability progression independent of relapse activity in multiple sclerosis. Multiple sclerosis journal - experimental, translational and clinical 6 (4) (2020)
Gabriel Bsteh, Thomas Berger
Commentary on "Lymphocytic colitis in the setting of teriflunomide use for relapsing multiple sclerosis". Multiple sclerosis (Houndmills, Basingstoke, England) 26 (13) (2020)
Thomas Berger, Monika Adamczyk-Sowa, Tünde Csépány, Franz Fazekas, Tanja Hojs Fabjan, Dana Horáková, Alenka Horvat Ledinek, Zsolt Illes, Gisela Kobelt, Saša Šega Jazbec, Eleonóra Klímová, Fritz Leutmezer, Konrad Rejdak, Csilla Rozsa, Johann Sellner, Krzysztof Selmaj, Pavel Štouracˇ, Jarmila Szilasiová, Peter Turcˇáni, Marta Vachová, Manuela Vanecková, László Vécsei, Eva Kubala Havrdová
Factors influencing daily treatment choices in multiple sclerosis: practice guidelines, biomarkers and burden of disease. Therapeutic advances in neurological disorders 13 (2020)
Gabriel Bsteh, Klaus Berek, Harald Hegen, Arabella Buchmann, Margarete Maria Voortman, Michael Auer, Sebastian Wurth, Anne Zinganell, Franziska Di Pauli, Florian Deisenhammer, Micheal Khalil, Thomas Berger
Serum neurofilament light levels correlate with change of olfactory function in multiple sclerosis. Multiple sclerosis journal - experimental, translational and clinical 5 (4) (2019)
Gabriel Bsteh, Klaus Berek, Harald Hegen, Barbara Teuchner, Arabella Buchmann, Margarete Maria Voortman, Michael Auer, Sebastian Wurth, Anne Zinganell, Franziska Di Pauli, Florian Deisenhammer, Micheal Khalil, Thomas Berger
Serum neurofilament levels correlate with retinal nerve fiber layer thinning in multiple sclerosis. Multiple sclerosis (Houndmills, Basingstoke, England) 26 (13) (2019)
Gabriel Bsteh, David Haschka, Piotr Tymoszuk, Klaus Berek, Verena Petzer, Harald Hegen, Sebastian Wurth, Michael Auer, Anne Zinganell, Franziska Di Pauli, Florian Deisenhammer, Guenter Weiss, Thomas Berger
Serum hepcidin levels in multiple sclerosis. Multiple sclerosis journal - experimental, translational and clinical 5 (4) (2019)
Thomas Berger, B Brochet, L Brambilla, Paul S Giacomini, X Montalbán, A Vasco Salgado, R Su, A Bretagne
Effectiveness of delayed-release dimethyl fumarate on patient-reported outcomes and clinical measures in patients with relapsing-remitting multiple sclerosis in a real-world clinical setting: PROTEC. Multiple sclerosis journal - experimental, translational and clinical 5 (4) (2019)

Thomas Berger.css-eqlu8i{font-size:small;padding-left:4px;} (T Berger)

Publication Activity (10 Years)

Top Topics

Top Venues

Thomas Berger (T Berger)